Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2010, Vol. 32 ›› Issue (11): 706-709.

Previous Articles     Next Articles

Investigation of the second-line anti-TB drugs usage in specialist hospitals and tuberculosis control institutions

Li Wenjing1; Sun Qiang1; Yan Yun1; Bian Xuefeng1,2; Zhang Jiasheng1; Geng Cheng3; Li Renzhong3   

  1. 1.Center for Health Management and Policy; Shandong University; Jinan 250012; China; 2.Jinan Center for Disease Control and Prevention; Jinan 250001; 3.National Center for Tuberculosis Control and Prevention China CDC; Beijing 102206;
  • Online:2010-11-15 Published:2011-08-23

Abstract: Objective To understand the use of second-line anti-TB drugs in TB specialist hospitals and tuberculosis control institutions.Methods Five provinces were selected in China as research sites.The patient medical records were randomly selected for investigation,corresponding key persons were interviewed.Results The proportion of second-line anti-TB drug use in patients has already reached 56.3%.There are a variety of second line drugs.Among which,Levofloxacin in two institutions is the mostly used,respectively...

Key words: hospitals, specialist, tuberculosis/drug therapy